{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T12:20:59Z","timestamp":1719922859205},"reference-count":7,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.taap.2019.03.002","type":"journal-article","created":{"date-parts":[[2019,3,7]],"date-time":"2019-03-07T03:49:55Z","timestamp":1551930595000},"page":"131-132","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Potential Problems with Determining Elongate Mineral Particle (EMP) Potency (Comments on article entitled, \u201cA Comparison of Asbestos Fiber Potency and Elongate Mineral Particle (EMP) Potency for Mesothelioma in Humans\u201d)"],"prefix":"10.1016","volume":"370","author":[{"given":"Jeffrey H.","family":"Mandel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nnaemeka U.","family":"Odo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce H.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2019.03.002_bb0005","author":"Agency for Toxic Substances and Disease Registry"},{"key":"10.1016\/j.taap.2019.03.002_bb0010","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1016\/j.yrtph.2007.09.020","article-title":"An evaluation of the risks of lung cancer and mesothelioma from exposure to amphibole cleavage fragments","volume":"52","author":"Gamble","year":"2008","journal-title":"Regulatory Tox and Pharmacology"},{"key":"10.1016\/j.taap.2019.03.002_bb2000","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.taap.2018.07.003","article-title":"A comparison of asbestos fiber potency and elongate mineral particle (EMP) potency for mesothelioma in humans","volume":"361","author":"Garabrant","year":"2018","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2019.03.002_bb0015","series-title":"Toxicology and Applied Pharmacology (the Monticello Conference on Elongated Mineral Particles Special Issue)","first-page":"145","article-title":"Session III: human exposure, effects and risk","volume":"vol. 361","author":"Gibbs","year":"2018"},{"key":"10.1016\/j.taap.2019.03.002_bb0020","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0003-4878(00)00045-4","article-title":"The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure","volume":"14","author":"Hodgson","year":"2000","journal-title":"Ann. Occup. Hyg."},{"issue":"8","key":"10.1016\/j.taap.2019.03.002_bb0025","first-page":"966","article-title":"Comprehensive assessment of exposures to elongate mineral particles in the taconite mining industry","volume":"57","author":"Hwang","year":"2013","journal-title":"Ann. Occup. Hyg."},{"issue":"12","key":"10.1016\/j.taap.2019.03.002_bb0030","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/ajim.22641","article-title":"A review of mortality associated with elongate mineral particle (EMP) exposure in occupational epidemiology studies of gold, talc, and taconite mining","volume":"59","author":"Mandel","year":"2016","journal-title":"Am. J. Ind. Med."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X19300845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X19300845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T13:33:01Z","timestamp":1576848781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X19300845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":7,"alternative-id":["S0041008X19300845"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2019.03.002","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential Problems with Determining Elongate Mineral Particle (EMP) Potency (Comments on article entitled, \u201cA Comparison of Asbestos Fiber Potency and Elongate Mineral Particle (EMP) Potency for Mesothelioma in Humans\u201d)","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2019.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}